Status:
UNKNOWN
The Efficacy of Neiguan (P6 Point) Acupressure in Patients With Gastroesophageal Reflux Disease (GERD)
Lead Sponsor:
China Medical University Hospital
Conditions:
Gastroesophageal Reflux Disease
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
In recent years, there is an increasing trend in the number of patients with Gastroesophageal reflux disease (GERD). The poor response to medicine was noticed in patients with non-erosive reflux disea...
Detailed Description
In recent years, there is an increasing trend in the number of patients with GERD. GERD mainly related to the reflux of stomach content induced by the dysfunction of lower esophageal sphincter. The co...
Eligibility Criteria
Inclusion
- Male or female
- Age of 20-60 years
- Suffered from heartburn with or without acid regurgitation
Exclusion
- Suffered from peptic ulcer, gallstones, cancer, and Barrett's esophagus
- previously underwent the esophagus, stomach or duodenum surgery
- Lactating women or pregnant women
- patients with severe cardiovascular disease
Key Trial Info
Start Date :
June 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT02255071
Start Date
June 1 2014
End Date
December 1 2015
Last Update
June 10 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Hospital
Taichung, Taiwan, 404